Flower power may reduce resistance to breast cancer drug tamoxifen

Combining tamoxifen, the world’s most prescribed breast cancer agent, with a compound found in the flowering plant feverfew may prevent initial or future resistance to the drug, say researchers. The finding provides new insight into the biological roots of that resistance, and also tests a novel way to get around it.